-
evolution of drug resistance in breast cancer with a specific interest in topoisomerase-1 inhibitor antibody-drug conjugates (TOP1i-ADCs). As a member of the Genomics, Genetics and Epigenetics research
-
compounds that enhance the activity of existing antifungal agents, reverse antifungal resistance, and reduce drug-associated toxicity. These studies build on our recent publications describing pantothenate
Searches related to resistive
Enter an email to receive alerts for resistive positions